A volunteer receives an injection from a medical worker. REUTERS/Siphiwe Sibeko
The Food and Drug Administration’s (FDA) panel of experts questioned the safety standards of the agency’s COVID-19 vaccine approval at an advisory meeting Thursday.
Independent experts in the FDA’s vaccine advisory board said they were concerned about a vaccine being rushed out, and later proving unsafe or ineffective, per Bloomberg.
The FDA requires a two-month follow-up after a final vaccine dose before emergency approval of a vaccine. This is too short, the experts said.
“What we’re being asked to do is to build this plane as we fly it,” said Archana Chatterjee, dean of Chicago Medical School.